CD8A and neoplasm: These results suggest that NK cells and CD8+ T cells play a critical role in anti-tumor activity of alum-CpG-HH2-NY vaccine, while CD4+ T cells may be a potent inducer of humoral immunity and make partial contribution to anti-tumor immunity of alum-CpG-HH2-NY.